Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
CHU Grenoble Alpes, UM GI-DPI, 38000, Grenoble, France.
Hum Genet. 2021 Jan;140(1):43-57. doi: 10.1007/s00439-020-02229-0. Epub 2020 Oct 27.
Globozoospermia is a rare phenotype of primary male infertility inducing the production of round-headed spermatozoa without acrosome. Anomalies of DPY19L2 account for 50-70% of all cases and the entire deletion of the gene is by far the most frequent defect identified. Here, we present a large cohort of 69 patients with 20-100% of globozoospermia. Genetic analyses including multiplex ligation-dependent probe amplification, Sanger sequencing and whole-exome sequencing identified 25 subjects with a homozygous DPY19L2 deletion (36%) and 14 carrying other DPY19L2 defects (20%). Overall, 11 deleterious single-nucleotide variants were identified including eight novel and three already published mutations. Patients with a higher rate of round-headed spermatozoa were more often diagnosed and had a higher proportion of loss of function anomalies, highlighting a good genotype phenotype correlation. No gene defects were identified in patients carrying < 50% of globozoospermia while diagnosis efficiency rose to 77% for patients with > 50% of globozoospermia. In addition, results from whole-exome sequencing were scrutinized for 23 patients with a DPY19L2 negative diagnosis, searching for deleterious variants in the nine other genes described to be associated with globozoospermia in human (C2CD6, C7orf61, CCDC62, CCIN, DNAH17, GGN, PICK1, SPATA16, and ZPBP1). Only one homozygous novel truncating variant was identified in the GGN gene in one patient, confirming the association of GGN with globozoospermia. In view of these results, we propose a novel diagnostic strategy focusing on patients with at least 50% of globozoospermia and based on a classical qualitative PCR to detect DPY19L2 homozygous deletions. In the absence of the latter, we recommend to perform whole-exome sequencing to search for defects in DPY19L2 as well as in the other previously described candidate genes.
全球精症是一种罕见的原发性男性不育表型,导致产生无头精子,没有顶体。DPY19L2 基因突变占所有病例的 50-70%,而迄今为止最常见的缺陷是该基因的全部缺失。在这里,我们报告了一个由 69 名患者组成的大队列,他们的全球精症比例为 20-100%。遗传分析包括多重连接依赖性探针扩增、Sanger 测序和全外显子组测序,确定了 25 名患者存在 DPY19L2 纯合缺失(36%)和 14 名患者携带其他 DPY19L2 缺陷(20%)。总体而言,鉴定出 11 个有害的单核苷酸变异,包括 8 个新的和 3 个已发表的突变。具有较高比例无头精子的患者更常被诊断出来,并且具有更高比例的功能丧失异常,突出了良好的基因型表型相关性。在携带 < 50%全球精症的患者中未发现基因缺陷,而在携带 > 50%全球精症的患者中,诊断效率上升到 77%。此外,对 23 名 DPY19L2 阴性诊断的患者进行了全外显子组测序分析,在另外 9 个被描述为与人类全球精症相关的基因(C2CD6、C7orf61、CCDC62、CCIN、DNAH17、GGN、PICK1、SPATA16 和 ZPBP1)中搜索有害变异。在一名患者的 GGN 基因中仅鉴定出一个纯合的新型截断变异,证实了 GGN 与全球精症的关联。鉴于这些结果,我们提出了一种新的诊断策略,重点关注至少 50%全球精症的患者,并基于经典的定性 PCR 来检测 DPY19L2 纯合缺失。在不存在后者的情况下,我们建议进行全外显子组测序,以寻找 DPY19L2 以及其他先前描述的候选基因中的缺陷。